Author
@howardlindzon howardlindzon
grade Cx.com/howardlindzon ↗
Fintech-founder pundit riffing AI/semi as 1999 redux with disclosed long bets
Posts short real-time market commentary, thematic narratives
trader score
-1.52
hit rate
35%
mean α
-1.55%
signals 14d
8
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 17 scored bets: 35% hit rate, -1.55% mean alpha, trader score -1.52. Their last-14d mentions, direction-adjusted, have moved +6.5% since posting (mean over 3 mentions with price data).
Recent signals8receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-15 | · | @howardlindzon | · | Expresses constructive surprise that markets remain resilient despite numerous macro risks. | · | tweet ↗ |
| 2026-10-15 | · | @howardlindzon | · | Argues Nvidia leadership now backstops AI hardware, warning momentum shorts against the sector. | · | tweet ↗ |
| 2026-10-14 | CRWV | @howardlindzon | -0.90 | Calls CoreWeave a financial-era monstrosity and expresses disgust. | -17.6% | tweet ↗ |
| 2026-10-12 | VIX | @howardlindzon | -0.20 | Author humorously states a very low implied VIX level | · | tweet ↗ |
| 2026-10-11 | ARKG | @howardlindzon | +0.50 | Author discloses existing long positions in ARKG and Lilly. | -6.1% | tweet ↗ |
| 2026-10-11 | LLY | @howardlindzon | +0.50 | Author discloses existing long positions in ARKG and Lilly. | +8.0% | tweet ↗ |
| 2026-10-11 | · | @howardlindzon | · | Author uses Stocktwits Momentum 25 lists to begin the investing week. | · | tweet ↗ |
| 2026-10-05 | · | @howardlindzon | · | Newsletter headline states that technology stocks remain market leaders. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.